Effects of choledochojejunostomy with Roux-en-Y exclusion on dimethylhydrazine induced neoplasms in rats.
The role of biliary secretions was studied in the development of neoplasms in the small intestine and colon of rats treated with 1,2-dimethylhydrazine (DMH). Sixty-eight female Sprague-Dawley rats underwent either no operative procedure or choledochojejunostomy with or without a Roux-en-Y exclusion. All animals then received weekly subcutaneous injections of DMH at 20 mg/kg for 26 weeks and were subsequently sacrificed. The largest number of neoplasms was found in the proximal duodenum, within 3 cm distal to the pylorus, in the control as well as both operative groups. In addition, only six neoplasms developed in relation to the choledochojejunostomy site in rats undergoing choledochojejunostomy only, and no neoplasms were noted at this location in the animals undergoing choledochojejunostomy with Roux-en-Y exclusion. These results suggest that the distribution of enteric neoplasms in DMH treated rats does not depend on excretion of active carcinogen in bile.
D019813:1,2-Dimethylhydrazine; D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D001646:Bile / Q000502:physiology*; D003110:Colonic Neoplasms / Q000139:chemically induced; D003135:Common Bile Duct / Q000601:surgery*; D004127:Dimethylhydrazines / Q000633:toxicity*; D005260:Female; D007414:Intestinal Neoplasms / Q000139:chemically induced* / Q000473:pathology; D007583:Jejunum / Q000601:surgery*; D008722:Methods; D008763:Methylhydrazines / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains
D004127:Dimethylhydrazines; D008763:Methylhydrazines; D019813:1,2-Dimethylhydrazine